Hepion Pharmaceuticals Inc Sustainability Reports
Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused primarily on the development of targeted therapies for chronic liver diseases.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493004WF12U6NOV8U20
FIGI: BBG005Y0S0K7
1 reports from 2023 to 2023
